Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Donald Eliot Goodkin · SciRah

Researcher profile · Semantic Scholar

Donald Eliot Goodkin

Share profile

Donald Eliot Goodkin — researcher profile on SciRah

h-index: 55
Works: 118
Citations: 20K

Most-cited papers

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
W. Mcdonald, A. Compston, G. Edan, Donald Eliot Goodkin +12 more
2001Annals of Neurology7,142 citations Open access
Semantic Scholar
Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis
L. Jacobs, D. Cookfair, R. Rudick, R. Herndon +22 more
1996Annals of Neurology2,516 citations
Semantic Scholar
A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex
J. Haines, M. Ter-Minassian, A. Bazyk, J. Gusella +24 more
1996Nature Genetics686 citations
Semantic Scholar
Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis.
D. Mohr, A. Boudewyn, Donald Eliot Goodkin, A. Bostrom +1 more
2001Journal of Consulting and Clinical Psychology342 citations
Semantic Scholar
Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis
R. Rudick, N. Simonian, J. Alam, M. Campion +13 more
1998Neurology331 citations
Semantic Scholar
Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis.
D. Mohr, Donald Eliot Goodkin, W. Likosky, N. Gatto +2 more
1997Archives of Neurology329 citations
Semantic Scholar
Magnetic resonance studies of intramuscular interferon β–1a for relapsing multiple sclerosis
J. Simon, L. Jacobs, M. Campion, K. Wende +31 more
1998319 citations
Semantic Scholar
Low‐dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis
Donald Eliot Goodkin, R. Rudick, S. Medendorp, M. Daughtry +3 more
1995Annals of Neurology313 citations
Semantic Scholar
Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group.
J. Haines, H. Terwedow, Katie Burgess, M. Pericak-Vance +9 more
1998Human Molecular Genetics297 citations
Semantic Scholar
The psychosocial impact of multiple sclerosis: exploring the patient's perspective.
D. Mohr, Leah P. Dick, David Russo, Jodi Pinn +3 more
1999Health Psychology290 citations
Semantic Scholar
Neuropsychological effects of interferon β‐1a in relapsing multiple sclerosis
J. Fischer, R. Priore, L. Jacobs, D. Cookfair +18 more
2000269 citations
Semantic Scholar
Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis.
E. Waubant, Donald Eliot Goodkin, L. Gee, P. Bacchetti +5 more
1999Neurology251 citations
Semantic Scholar
Telephone-administered cognitive-behavioral therapy for the treatment of depressive symptoms in multiple sclerosis.
D. Mohr, W. Likosky, A. Bertagnolli, Donald Eliot Goodkin +3 more
2000Journal of Consulting and Clinical Psychology241 citations
Semantic Scholar
Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis
R. Rudick, Donald Eliot Goodkin, L. Jacobs, D. Cookfair +24 more
1997Neurology237 citations
Semantic Scholar
A serial study of new MS lesions and the white matter from which they arise
Donald Eliot Goodkin, W. Rooney, R. Sloan, P. Bacchetti +7 more
1998Neurology215 citations
Semantic Scholar
Treatment of depression is associated with suppression of nonspecific and antigen-specific T(H)1 responses in multiple sclerosis.
D. Mohr, Donald Eliot Goodkin, Janeen Islar, S. Hauser +1 more
2001Archives of Neurology193 citations
Semantic Scholar
Psychological stress and the subsequent appearance of new brain MRI lesions in MS
D. Mohr, Donald Eliot Goodkin, P. Bacchetti, A. Boudewyn +4 more
2000Neurology188 citations
Semantic Scholar
Cardiac adverse effects associated with mitoxantrone (Novantrone) therapy in patients with MS
R. Ghalie, G. Edan, M. Laurent, E. Mauch +5 more
2002Neurology177 citations
Semantic Scholar
Injectable medication for the treatment of multiple sclerosis: The influence of self-efficacy expectations and infection anxiety on adherence and ability to self-inject
D. Mohr, A. Boudewyn, W. Likosky, Ellen G. Levine +1 more
2001Annals of Behavioral Medicine168 citations
Semantic Scholar
Identifying multiple sclerosis patients with mild or global cognitive impairment using the Screening Examination for Cognitive Impairment (SEFCI)
William W. Beatty, R. H. Paul, Susan L. Wilbanks, Karen A. Hames +2 more
1995Neurology162 citations
Semantic Scholar
A study of therapy-related acute leukaemia after mitoxantrone therapy for multiple sclerosis
R. Ghalie, E. Mauch, G. Edan, H.-P. Hartung +5 more
2002Multiple Sclerosis157 citations
Semantic Scholar
Side effect profile of interferon beta-1b in MS: results of an open label trial.
Laura K. Neilley, D. Goodin, Donald Eliot Goodkin, S. Hauser
1996Neurology150 citations
Semantic Scholar
Therapeutic expectations of patients with multiple sclerosis upon initiating interferon beta-lb: Relationship to adherence to treatment
D. Mohr, Donald Eliot Goodkin, W. Likosk, N. Gatto +3 more
1996Multiple Sclerosis146 citations
Semantic Scholar
Depression, coping and level of neurological impairment in multiple sclerosis
D. Mohr, Donald Eliot Goodkin, N. Gatto, J. Van Der Wende
1997Multiple Sclerosis136 citations
Semantic Scholar
CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis
L. Barcellos, A. Schito, J. Rimmler, E. Vittinghoff +9 more
2000Immunogenetics135 citations
Semantic Scholar
Treatment of Depression in Multiple Sclerosis: Review and Meta‐analysis
D. Mohr, Donald Eliot Goodkin
2006130 citations
Semantic Scholar
Drugs Used to Treat Spasticity
M. Kita, Donald Eliot Goodkin
2000Drugs118 citations
Semantic Scholar
Identification of Beck Depression Inventory Items Related to Multiple Sclerosis
D. Mohr, Donald Eliot Goodkin, W. Likosky, L. Beutler +2 more
1997Journal of behavioral medicine115 citations
Semantic Scholar
1H MRSI comparison of white matter and lesions in primary progressive and relapsing-remitting MS
J. Suhy, W. Rooney, Donald Eliot Goodkin, A. Capizzano +5 more
2000Multiple Sclerosis111 citations Open access
Semantic Scholar
IFNβ lowers MMP-9/TIMP-1 ratio, which predicts new enhancing lesions in patients with SPMS
E. Waubant, Donald Eliot Goodkin, A. Bostrom, P. Bacchetti +3 more
2003Neurology105 citations
Semantic Scholar
Interferon Beta-1a in Children with Multiple Sclerosis is Well Tolerated
E. Waubant, J. Hietpas, T. Stewart, Z. Dyme +6 more
2001Neuropediatrics97 citations
Semantic Scholar
A phase II study of IV methylprednisolone in secondary-progressive multiple sclerosis
Donald Eliot Goodkin, R. Kinkel, B. Weinstock-Guttman, S. V. Medendorp +5 more
1998Neurology95 citations
Semantic Scholar
A meta-analysis of genomic screens in multiple sclerosis. The Transatlantic Multiple Sclerosis Genetics Cooperative.
M. Pericak-Vance, J. Rimmler, A. Saunders, E. Martin +19 more
2001Multiple Sclerosis94 citations
Semantic Scholar
Multiple sclerosis that is progressive from the time of onset: clinical characteristics and progression of disability.
P. Andersson, E. Waubant, L. Gee, Donald Eliot Goodkin
1999Archives of Neurology94 citations Open access
Semantic Scholar
Glucocorticosteroid therapy for multiple sclerosis: a critical review.
P. Andersson, Donald Eliot Goodkin
1998Journal of Neurological Sciences87 citations
Semantic Scholar
1H MRSI of normal appearing white matter in multiple sclerosis
W. Rooney, Donald Eliot Goodkin, N. Schuff, D. Meyerhoff +2 more
1997Multiple Sclerosis87 citations
Semantic Scholar
Moderating Effects of Coping on the Relationship Between Stress and the Development of New Brain Lesions in Multiple Sclerosis
D. Mohr, Donald Eliot Goodkin, S. Nelson, D. Cox +1 more
2002Psychosomatic Medicine85 citations Open access
Semantic Scholar
Side effect profile and adherence to in the treatment of Multiple Sclerosis with interferon beta-la
D. Mohr, W. Likosky, A. Boudewyn, Peter Marietta +3 more
1998Multiple Sclerosis79 citations
Semantic Scholar
Cerebrospinal fluid abnormalities in a phase III trial of Avonex® (IFNβ-1a) for relapsing multiple sclerosis
R. Rudick, D. Cookfair, N. Simonian, R. Ransohoff +25 more
199976 citations
Semantic Scholar
Eight-year immunogenicity and safety of interferon beta-1a-Avonex®treatment in patients with multiple sclerosis
R. Herndon, R. Rudick, F. Munschauer, M. Mass +9 more
2005Multiple Sclerosis69 citations
Semantic Scholar
Relationship between serum levels of IL-10, MRI activity and interferon beta-1a therapy in patients with relapsing remitting MS.
E. Waubant, L. Gee, P. Bacchetti, R. Sloan +3 more
2001Journal of Neuroimmunology65 citations
Semantic Scholar
A phase I trial of solubilized DR2:MBP84-102 (AG284) in multiple sclerosis
Donald Eliot Goodkin, M. Shulman, J. Winkelhake, Emmanuelle Waubant +10 more
2000Neurology58 citations
Semantic Scholar
Low-dose oral methotrexate in chronic progressive multiple sclerosis
Donald Eliot Goodkin, R. Rudick, S. Medendorp, M. Daughtry +1 more
1996Neurology57 citations
Semantic Scholar
Course of depression during the initiation of interferon beta-1a treatment for multiple sclerosis.
D. Mohr, W. Likosky, Pat Dwyer, Judy Van Der Wende +2 more
1999Archives of Neurology56 citations
Semantic Scholar
MRI lesion volume heterogeneity in primary progressive MS in relation with axonal damage and brain atrophy
D. Pelletier, S. Nelson, Joonmi Oh, Jack P. Antel +3 more
2003Journal of Neurology Neurosurgery & Psychiatry52 citations Open access
Semantic Scholar
A longitudinal study of ventricular volume in early relapsing-remitting multiple sclerosis
T. Luks, Donald Eliot Goodkin, Sarah J. Nelson, Sharmila Majumdar +3 more
2000Multiple Sclerosis52 citations
Semantic Scholar
Serum cobalamin deficiency is uncommon in multiple sclerosis.
Donald Eliot Goodkin, D. Jacobsen, Nestor Galvez, M. Daughtry +2 more
1994Archives of Neurology50 citations
Semantic Scholar
Magnetic resonance imaging lesion enlargement in multiple sclerosis. Disease-related activity, chance occurrence, or measurement artifact?
Donald Eliot Goodkin, Jeffery S. Ross, S. V. Medendorp, Jan Konecsni +1 more
1992Archives of Neurology48 citations
Semantic Scholar
Treatment adherence and patient retention in the first year of a Phase-III clinical trial for the treatment of multiple sclerosis
D. Mohr, Donald Eliot Goodkin, L. Masuoka, Leah P. Dick +4 more
1999Multiple Sclerosis45 citations
Semantic Scholar
Guidelines for physicians with patients on IFN beta-1b
D. Paty, Donald Eliot Goodkin, Alan Thompson, G. Rice
1996Neurology40 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Rudick×12
Invite
R. Rudick — researcher profile on SciRah
D. Mohr×11
Invite
D. Mohr — researcher profile on SciRah
R. Herndon×7
Invite
R. Herndon — researcher profile on SciRah
J. Richert×7
Invite
J. Richert — researcher profile on SciRah

×7

Invite

A. Boudewyn — researcher profile on SciRah

Invite

E. Waubant — researcher profile on SciRah

Invite

L. Jacobs — researcher profile on SciRah

Invite

D. Cookfair — researcher profile on SciRah

Invite

A. Salazar — researcher profile on SciRah

Invite

J. Simon — researcher profile on SciRah

Invite

M. Coats — researcher profile on SciRah

Invite

M. Mass — researcher profile on SciRah